Source: US National Institute of Justice (video statements)
This presentation is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
With the passage of the 2018 Agricultural Improvement Act (Farm Bill), forensic laboratories have been tasked with differentiating seized cannabis samples as either hemp or marijuana. The new legislation declassified hemp as a Schedule 1 drug substance and defined it as cannabis containing 0.3 % or less of decarboxylated-Δ9-THC (total Δ9-THC). The National Institute of Standards and Technology (NIST) has been working to help forensic laboratories with these challenging measurements through the development of extraction protocols and analytical methods. This webinar provides a summary of the method development studies and screening of cannabis plant and cannabis-derived finished products commercially available.
This webinar was hosted by the NIJ Forensic Technology Center of Excellence on June 27, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
The reauthorization of hemp due to the Agriculture Improvement Act of 2018 (Farm Bill) has caused a proliferation of products that contain cannabidiol (CBD). While CBD is considered ‘legal’ under the Farm-Bill, there are concerns that the labeling of CBD products is inaccurate, and that the products may contain other cannabinoids, including Δ9-tetrahydrocannabinol (THC), the main psychoactive compound in marijuana. Other concerns include the potential for conversion of CBD to other cannabinoids during analysis of biological matrices and in acidic foods and beverages. Incorrect labeling and/or conversion can lead to false positives during analysis and unintentional ingestion of THC, which may result in impairment and/or positive drug tests. In this presentation, Dr. Lawrance Mullen provides a landscape of the public health impact of CBD, the importance of proper analytical technique to prevent false positive drug tests, and the results of a study conducted on acidic foods and beverages.
This webinar was hosted by the NIJ Forensic Technology Center of Excellence on May 18, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
Dr. Julie L. Valentine provides background information on the challenges in tracking prosecution outcomes in sexual assault cases of adult victims. Research utilizing the National Institute of Justice Sexual Assault Nurse Examiner Practitioner Toolkit in two Utah counties is presented. Variables predicting prosecution are be explored. Participants are invited to consider societal, structural, and legislative barriers to prosecution of adult sexual assault cases faced in their jurisdiction to encourage multidisciplinary collaboration.
This webinar was hosted by the NIJ Forensic Technology Center of Excellence on April 24, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
Dr. Julie Valentine shares background information on dating app usage and user demographics to provide context for research findings on dating apps and sexual assault. Research findings are presented on sexual assaults committed at the first in-person meeting when the victim and assailant met on a dating app compared to other sexual assaults not associated with dating apps. Practice and policy recommendations are shared to improve dating app safety.
This webinar was hosted by the NIJ Forensic Technology Center of Excellence on April 4, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
